Cargando…
Rapid control of pandemic H1N1 influenza by targeting NKT-cells
Swine influenza A viruses (IAV) are a major cause of respiratory disease in pigs and humans. Currently approved anti-influenza therapies directly target the virus, but these approaches are losing effectiveness as new viral strains quickly develop drug resistance. To over come this challenge, there i...
Autores principales: | Artiaga, Bianca L., Yang, Guan, Hutchinson, Tarun E., Loeb, Julia C., Richt, Jürgen A., Lednicky, John A., Salek-Ardakani, Shahram, Driver, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126553/ https://www.ncbi.nlm.nih.gov/pubmed/27897246 http://dx.doi.org/10.1038/srep37999 |
Ejemplares similares
-
α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
por: Artiaga, Bianca L., et al.
Publicado: (2016) -
Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
por: Madrid, Darling Melany de C., et al.
Publicado: (2022) -
Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017) -
Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
por: Driver, John P., et al.
Publicado: (2020) -
The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018)